Literature DB >> 6417014

Strain distribution in extents of lysozyme resistance and O-acetylation of gonococcal peptidoglycan determined by high-performance liquid chromatography.

S C Swim, M A Gfell, C E Wilde, R S Rosenthal.   

Abstract

The extent of lysozyme resistance and O-acetylation of purified peptidoglycan (PG) from 20 strains of Neisseria gonorrhoeae was examined to determine how widespread these properties are among various subsets of gonococcal isolates. To determine digestibility by lysozyme, we treated [3H]- or [14C]glucosamine-labeled PG with hen egg white lysozyme (HEW-LZ) and determined the size distribution of HEW-LZ soluble PG at the completion of the reaction by molecular-sieve high-performance liquid chromatography, using a Varian TSK SW2000 column, a method that proved considerably more efficient than traditional chromatography for fractionating low-molecular-weight PG fragments solely on the basis of size. The extent of HEW-LZ resistance was expressed as the percentage of PG that was larger in size than disaccharide peptide tetramers (including insoluble PG removed by centrifugation). The percent O-acetylation was determined by converting insoluble PG totally to uncross-linked monomers by the combined action of Chalaropsis B muramidase followed by Escherichia coli endopeptidase and then quantitating radioactivity in O-acetylated and non-O-acetylated monomers after paper chromatography. The PG of the vast majority (19 of 20) of gonococcal strains examined was extensively HEW-LZ resistant (range, 40 to 60% larger than tetramers) and extensively O-acetylated (range, 34 to 52%). Only the PG of strain RD5 (highest rate of PG turnover among gonococci so far examined and the prototype of gonococci having O-acetyl-deficient PG) had greatly reduced O-acetylation (15%) and exhibited virtually no HEW-LZ resistance (2% larger than tetramers). Extensive HEW-LZ resistance and O-acetylation were apparently not associated specifically with (i) a given type of colonial variant (piliated versus nonpiliated or opaque versus transparent), (ii) a given type of clinical isolate (local versus disseminated), (iii) the extent of laboratory passage, or (iv) (with the possible exception of penicillin-resistant strain FA102) the presence of one or more genetic loci governing antibiotic resistance among members of an isogenic set of gonococci. From this survey, we conclude that lysozyme resistance and extensive O-acetylation of PG are widespread among gonococci and, thus, that most strains are potential sources of hydrolase-resistant PG that conceivably could persist as macromolecular fragments in vivo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6417014      PMCID: PMC264450          DOI: 10.1128/iai.42.2.446-452.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Cell envelope alterations in antibiotic-sensitive and-resistant strains of Neisseria gonorrhoeae.

Authors:  L F Guymon; D L Walstad; P F Sparling
Journal:  J Bacteriol       Date:  1978-10       Impact factor: 3.490

2.  Modification of peptidoglycan structure by penicillin action in cell walls of Proteus mirabilis.

Authors:  H H Martin; J Gmeiner
Journal:  Eur J Biochem       Date:  1979-04

3.  Cell envelope of Neisseria gonorrhoeae: relationship between autolysis in buffer and the hydrolysis of peptidoglycan.

Authors:  W S Wegener; B H Hebeler; S A Morse
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

4.  The wall peptidoglycans of Neisseria perflava, Moraxella glucidolytica, Pseudomonas alcaligenes and Proteus vulgaris strain P18.

Authors:  J P Martin; J Fleck; M Mock; J M Ghuysen
Journal:  Eur J Biochem       Date:  1973-10-05

5.  Studies on gonococcus infection. XII. Colony color and opacity varienats of gonococci.

Authors:  J Swanson
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

6.  Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall.

Authors:  J Greenblatt; R J Boackle; J H Schwab
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

7.  Chemical composition and turnover of peptidoglycan in Neisseria gonorrhoeae.

Authors:  B H Hebeler; F E Young
Journal:  J Bacteriol       Date:  1976-06       Impact factor: 3.490

8.  Serogrouping of Neisseria gonorrhoeae: identification of four immunologically distinct acidic polysaccharides.

Authors:  M A Apicella
Journal:  J Infect Dis       Date:  1976-10       Impact factor: 5.226

9.  Ethylenediaminetetraacetic acid-sensitive antiphagocytic activity of Neisseria gonorrhoeae.

Authors:  R S Rosenthal; R S Fulbright; M E Eads; W D Sawyer
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

10.  Resistance of O-acetylated gonococcal peptidoglycan to human peptidoglycan-degrading enzymes.

Authors:  R S Rosenthal; W J Folkening; D R Miller; S C Swim
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

View more
  34 in total

1.  Characterization of a monoclonal antibody that binds to an epitope on soluble bacterial peptidoglycan fragments.

Authors:  G J Merkel; B A Scofield
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

Review 2.  Modifications to the peptidoglycan backbone help bacteria to establish infection.

Authors:  Kimberly M Davis; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

3.  Mutations affecting peptidoglycan acetylation in Neisseria gonorrhoeae and Neisseria meningitidis.

Authors:  Joseph P Dillard; Kathleen T Hackett
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Structural basis for the O-acetyltransferase function of the extracytoplasmic domain of OatA from Staphylococcus aureus.

Authors:  Carys S Jones; David Sychantha; P Lynne Howell; Anthony J Clarke
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

5.  O-acetylation of peptidoglycan in gram-negative bacteria: identification and characterization of peptidoglycan O-acetyltransferase in Neisseria gonorrhoeae.

Authors:  Patrick J Moynihan; Anthony J Clarke
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

6.  epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus.

Authors:  M Sugai; T Fujiwara; K Ohta; H Komatsuzawa; M Ohara; H Suginaka
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

7.  Degradation of gonococcal peptidoglycan by granule extract from human neutrophils: demonstration of N-acetylglucosaminidase activity that utilizes peptidoglycan substrates.

Authors:  R Striker; M E Kline; R A Haak; R F Rest; R S Rosenthal
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

8.  Peptidoglycan fragments decrease food intake and body weight gain in rats.

Authors:  K J Biberstine; R S Rosenthal
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Characterization of structural variations in the peptidoglycan of vancomycin-susceptible Enterococcus faecium: understanding glycopeptide-antibiotic binding sites using mass spectrometry.

Authors:  Gary J Patti; Jiawei Chen; Jacob Schaefer; Michael L Gross
Journal:  J Am Soc Mass Spectrom       Date:  2008-07-01       Impact factor: 3.109

10.  Extent of peptidoglycan O acetylation in the tribe Proteeae.

Authors:  A J Clarke
Journal:  J Bacteriol       Date:  1993-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.